[go: up one dir, main page]

NO20011738D0 - Heterocyclylaminometyloksazolidinoner som antibakterielle midler - Google Patents

Heterocyclylaminometyloksazolidinoner som antibakterielle midler

Info

Publication number
NO20011738D0
NO20011738D0 NO20011738A NO20011738A NO20011738D0 NO 20011738 D0 NO20011738 D0 NO 20011738D0 NO 20011738 A NO20011738 A NO 20011738A NO 20011738 A NO20011738 A NO 20011738A NO 20011738 D0 NO20011738 D0 NO 20011738D0
Authority
NO
Norway
Prior art keywords
heterocyclylaminomethyloxazolidinones
antibacterial agents
antibacterial
agents
Prior art date
Application number
NO20011738A
Other languages
English (en)
Other versions
NO20011738L (no
Inventor
Michael Barry Gravestock
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20011738D0 publication Critical patent/NO20011738D0/no
Publication of NO20011738L publication Critical patent/NO20011738L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20011738A 1998-10-09 2001-04-06 Heterocyclylaminometyloksazolidinoner som antibakterielle midler NO20011738L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9821938.9A GB9821938D0 (en) 1998-10-09 1998-10-09 Chemical compounds
PCT/GB1999/003299 WO2000021960A1 (en) 1998-10-09 1999-10-05 Heterocyclyl amino methyloxa zolidinones as antibacterials

Publications (2)

Publication Number Publication Date
NO20011738D0 true NO20011738D0 (no) 2001-04-06
NO20011738L NO20011738L (no) 2001-06-07

Family

ID=10840200

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011738A NO20011738L (no) 1998-10-09 2001-04-06 Heterocyclylaminometyloksazolidinoner som antibakterielle midler

Country Status (15)

Country Link
US (2) US6734200B1 (no)
EP (1) EP1121358A1 (no)
JP (1) JP2002527439A (no)
KR (1) KR20010085887A (no)
CN (1) CN1165534C (no)
AU (1) AU754123B2 (no)
BR (1) BR9914379A (no)
CA (1) CA2342623A1 (no)
GB (1) GB9821938D0 (no)
HU (1) HUP0103929A3 (no)
IL (1) IL142420A0 (no)
NO (1) NO20011738L (no)
NZ (1) NZ510211A (no)
WO (1) WO2000021960A1 (no)
ZA (1) ZA200102659B (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9821938D0 (en) * 1998-10-09 1998-12-02 Zeneca Ltd Chemical compounds
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
US6642238B2 (en) 2000-02-10 2003-11-04 Pharmacia And Upjohn Company Oxazolidinone thioamides with piperazine amide substituents
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
PE20030044A1 (es) 2000-11-17 2003-02-09 Upjohn Co Isoxazolinonas biciclicas de formula i
PE20020689A1 (es) * 2000-11-17 2002-08-03 Upjohn Co Oxazolidinonas con un heterociclo de 6 o 7 miembros unidos con enlace anular al benceno
GB0108793D0 (en) * 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
GB0113299D0 (en) * 2001-06-01 2001-07-25 Astrazeneca Ab Chemical process & intermediates
GB0113298D0 (en) * 2001-06-01 2001-07-25 Astrazeneca Ab Purification process and intermediates
GB0113300D0 (en) * 2001-06-01 2001-07-25 Astrazeneca Ab Purification process
EP1427711B1 (en) 2001-09-11 2005-07-13 AstraZeneca AB Oxazolidinone and/or isoxazoline derivatives as antibacterial agents
WO2003035073A1 (en) 2001-10-25 2003-05-01 Astrazeneca Ab Isoxazoline derivatives useful as antimicrobials
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AU2003207340A1 (en) 2002-02-28 2003-09-09 Astrazeneca Ab 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
BR0308018A (pt) 2002-02-28 2005-01-04 Astrazeneca Ab Composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo, pró-droga, método para produzir um efeito antibacteriano em um animal de sangue quente, uso de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hirolisável in vivo, composição farmacêutica, e, processo para a preparação de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo
DE60304360T2 (de) 2002-08-12 2006-11-16 Pharmacia & Upjohn Co. Llc, Kalamazoo N-aryl-2-oxazolidinone und deren derivate
US7091196B2 (en) * 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
US6875784B2 (en) 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
AR042086A1 (es) 2002-11-21 2005-06-08 Upjohn Co N-aril-2- oxazolidinon -5- carboxamidas y sus derivados, usados como agentes antibacterianos
GB0227701D0 (en) * 2002-11-28 2003-01-08 Astrazeneca Ab Chemical compounds
GB0229522D0 (en) * 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds
GB0229518D0 (en) * 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds
US7012088B2 (en) 2003-02-24 2006-03-14 Pharmacia & Upjohn Company Indolone oxazolidinones and derivatives thereof
JP2006522791A (ja) 2003-04-09 2006-10-05 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗微生物性［３．１．０］ビシクロヘキシルフェニルオキサゾリジノン誘導体および類似体
WO2004099199A1 (en) * 2003-05-06 2004-11-18 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
AR045690A1 (es) 2003-06-03 2005-11-09 Rib X Pharmaceuticals Inc Compuestos biaril heterociclicos y metodos para preparar y utilizar los mismos
WO2004113329A1 (en) * 2003-06-20 2004-12-29 Orchid Chemicals And Pharmaceuticals Ltd. Oxazole derivatives as antibacterial agents
WO2005003087A2 (en) * 2003-07-01 2005-01-13 Orchid Chemicals And Pharmaceuticals Ltd. Oxazole derivatives as antibacterial agents
US7687627B2 (en) * 2003-09-08 2010-03-30 Wockhardt Limited Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
EP1713785A1 (en) 2003-12-17 2006-10-25 Rib-X Pharmaceuticals, Inc. Halogenated biaryl heterocyclic compounds and methods of making and using the same
WO2005085266A2 (en) 2004-02-27 2005-09-15 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
US8399660B2 (en) 2005-06-08 2013-03-19 Rib-X Pharmaceuticals, Inc. Process for the synthesis of triazoles
WO2007025098A2 (en) 2005-08-24 2007-03-01 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
CN101798302B (zh) 2009-02-06 2014-11-05 上海盟科药业有限公司 抗生素类药物1-(邻-氟苯基)二氢吡啶酮的合成及生产的方法和工艺
US8916567B2 (en) 2009-11-04 2014-12-23 Universal Technology Alliance, Inc. Certain crystalline hydrates, pharmaceutical compositions thereof and methods for preparation and use thereof
WO2013182070A1 (zh) * 2012-06-08 2013-12-12 四川贝力克生物技术有限责任公司 一种用于预防或治疗分支杆菌疾病的药物
CA2907032C (en) * 2013-03-15 2021-04-20 I.E.Me.St - Istituto Euro Mediterraneo Di Scienza E Tecnologia 1, 2, 4-oxadiazol compounds active against gram-positive pathogens
WO2015127316A1 (en) 2014-02-21 2015-08-27 Micurx Pharmaceuticals, Inc. Water-soluble o-carbonyl phosphoramidate prodrugs for therapeutic administration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4705799A (en) 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
ES8506659A1 (es) 1983-06-07 1985-08-01 Du Pont Un procedimiento para la preparacion de nuevos derivados del amino-metil-oxooxazolidinil-benzeno.
DE19604223A1 (de) * 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
GB9821938D0 (en) * 1998-10-09 1998-12-02 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
HUP0103929A2 (hu) 2002-07-29
EP1121358A1 (en) 2001-08-08
WO2000021960A1 (en) 2000-04-20
HUP0103929A3 (en) 2002-08-28
ZA200102659B (en) 2002-07-01
US20030207899A1 (en) 2003-11-06
CN1165534C (zh) 2004-09-08
NZ510211A (en) 2003-05-30
KR20010085887A (ko) 2001-09-07
US6734200B1 (en) 2004-05-11
GB9821938D0 (en) 1998-12-02
BR9914379A (pt) 2001-08-07
US7087629B2 (en) 2006-08-08
AU754123B2 (en) 2002-11-07
JP2002527439A (ja) 2002-08-27
AU6113199A (en) 2000-05-01
NO20011738L (no) 2001-06-07
CN1322203A (zh) 2001-11-14
IL142420A0 (en) 2002-03-10
CA2342623A1 (en) 2000-04-20

Similar Documents

Publication Publication Date Title
NO20011738L (no) Heterocyclylaminometyloksazolidinoner som antibakterielle midler
PT1005356E (pt) Novos agentes antibacterianos
DK1028961T3 (da) Pleuromutilinderivater som antimikrobielle midler
NO20022888L (no) Lipopeptider som antibakterielle midler
DE69937339D1 (de) Bakterizide
NO20022887D0 (no) Lipopeptider som antibakterielle midler
DK2253620T3 (da) Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer
DK0869949T3 (da) Benzoxaziner som antimikrobielle midler
ID28698A (id) Formulasi antiparasit
DE69920730D1 (de) Wässrige zusammensetzung
NO20015722D0 (no) Antibakterielle forbindelser
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
DK1246810T3 (da) Piperidinyloxy- og pyrrolidinyloxyphenyloxazolidinoner som antibakterielle midler
DE59912684D1 (de) Folienförmige wirkstoffträger
NO20020621D0 (no) Antibakterielle midler
DK1181288T3 (da) Bicycliske oxazolidinoner som antibakterielle midler
ID27655A (id) Formulasi mikrokapsul
EP1005862A4 (en) ANTI-CHLAMYDIA MEDIUM
ATE248579T1 (de) Synergistische antibakterielle kombination
ATE217021T1 (de) Präparationsmittel
EP0961615A4 (en) ANTIMICROBIAL AGENT
DK1075471T3 (da) Idolylderivater som serotonerge midler
IT1307018B1 (it) Agenti antibatterici.
DE69906691D1 (de) Tuberkilizides desinfektionsmittel
FI980759A0 (fi) Taetningskonstruktion foer suglaodan i en sugvals

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application